Hugh Alexander Ilyine
Oprichter bij Profactor Pharma Ltd.
Profiel
Hugh Alexander Ilyine is the founder of two companies.
He founded Profactor Pharma Ltd.
in 2009 and Destina Genomics Ltd.
in 2011, where he holds the title of Director and Chief Executive Officer & Executive Director, respectively.
Mr. Ilyine's former jobs include Chief Operating Officer positions at Sierra Leone Diamond Co. Ltd.
and Stem Cell Sciences Plc.
Actieve functies van Hugh Alexander Ilyine
Bedrijven | Functie | Begin |
---|---|---|
Profactor Pharma Ltd.
Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Oprichter | 01-01-2009 |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Oprichter | 01-01-2011 |
Eerdere bekende functies van Hugh Alexander Ilyine
Bedrijven | Functie | Einde |
---|---|---|
Stem Cell Sciences Plc | Operationeel Directeur | 07-04-2009 |
Sierra Leone Diamond Co. Ltd. | Operationeel Directeur | 17-08-2007 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Sierra Leone Diamond Co. Ltd. | Non-Energy Minerals |
Stem Cell Sciences Plc | Commercial Services |
Profactor Pharma Ltd.
Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Health Technology |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |